Literature DB >> 10580296

c-Fos expression in the myenteric plexus, spinal cord and brainstem following injection of formalin in the rat colonic wall.

M Miampamba1, K A Sharkey.   

Abstract

Fos expression induced by injection of dilute formalin (50 microl, 5% in physiological saline) into the colonic wall was examined in the myenteric plexus, lumbosacral spinal cord and brainstem of the rat. The aims of this study were (i) to determine whether neurons in these regions express Fos in response to the injection of formalin into the colon and (ii) to examine whether administration of an alpha 2 adrenoceptor agonist modulates Fos expression. Tissues were removed 2 h after the injection of saline or formalin. Saline injected in the colon induced Fos in enteric glia in the myenteric plexus. The number of Fos immunoreactive nuclei significantly increased in both myenteric neurons and enteric glia after the injection of formalin. Similarly, Fos immunoreactive neuronal nuclei were significantly increased in the spinal cord, area postrema and nucleus of the solitary tract after the injection of formalin. Pretreatment of rats with the alpha 2 adrenoceptor agonist xylazine (2, 4 and 8 mg/kg) 15 min before the injection of formalin, dose-dependently reduced the number of Fos immunoreactive neuronal and glial nuclei in the myenteric plexus, and neuronal nuclei in the spinal cord and brainstem. Simultaneous administration of xylazine (8 mg/kg) and the alpha 2 adrenoceptor antagonist yohimbine (1 mg/kg) reversed the effects of xylazine in the spinal cord and brainstem, but not in the myenteric plexus. These data show that injection of formalin in the colonic wall results in Fos expression in myenteric neurons and enteric glia, and neurons in the spinal cord and brainstem. This may be due to the direct chemical stimulation of the innervation of the colon and/or the subsequent acute colitis. The observed neuronal Fos expression can be modulated by an alpha 2 adrenoceptor agonist through noradrenergic pathways and/or reduction of the excitability of the enteric neural circuitry.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580296

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  6 in total

1.  Acute cold exposure induces vagally mediated Fos expression in gastric myenteric neurons in conscious rats.

Authors:  P Q Yuan; Y Taché; M Miampamba; H Yang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-08       Impact factor: 4.052

2.  Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats.

Authors:  P-Q Yuan; M Million; S V Wu; J Rivier; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2007-08-10       Impact factor: 3.598

3.  COX-2 dependent inflammation increases spinal Fos expression during rodent postoperative ileus.

Authors:  C Kreiss; L A Birder; S Kiss; M M VanBibber; A J Bauer
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

4.  Water avoidance stress activates colonic myenteric neurons in female rats.

Authors:  Marcel Miampamba; Mulugeta Million; Pu-Qing Yuan; Muriel Larauche; Yvette Taché
Journal:  Neuroreport       Date:  2007-05-07       Impact factor: 1.837

5.  Expression of pituitary adenylate cyclase-activating polypeptide and PACAP type 1 receptor in the rat gastric and colonic myenteric neurons.

Authors:  Marcel Miampamba; Patrizia M Germano; Selin Arli; Helen H Wong; David Scott; Yvette Taché; Joseph R Pisegna
Journal:  Regul Pept       Date:  2002-05-30

6.  HIV-1 Tat-induced diarrhea evokes an enteric glia-dependent neuroinflammatory response in the central nervous system.

Authors:  Giuseppe Esposito; Elena Capoccia; Stefano Gigli; Marcella Pesce; Eugenia Bruzzese; Alessandra D'Alessandro; Carla Cirillo; Alessandro di Cerbo; Rosario Cuomo; Luisa Seguella; Luca Steardo; Giovanni Sarnelli
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.